Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation.
about
Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genesMammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic researchPrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesAh Receptor Pathway Intricacies; Signaling Through Diverse Protein Partners and DNA-MotifsA novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and disseminationKLF6 inhibited oral cancer migration and invasion via downregulation of mesenchymal markers and inhibition of MMP-9 activities.MDM2, MDMX and p53 in oncogenesis and cancer therapyIdentification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.Transcript profiling identifies iqgap2(-/-) mouse as a model for advanced human hepatocellular carcinoma.Telomerase activated thymidine analogue pro-drug is a new molecule targeting hepatocellular carcinoma.MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.MDM2-p53 pathway in hepatocellular carcinoma.Modulation of cardiac fibrosis by Krüppel-like factor 6 through transcriptional control of thrombospondin 4 in cardiomyocytes.Oxidative stress modulates KLF6Full and its splice variants.Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing.Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis.Krüppel-like factors in hepatocellular carcinoma.Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.Selecting optimal combinations of transcription factors to promote axon regeneration: Why mechanisms matter.p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks.Effects of Kruppel-like factor 6 on osteosarcoma cell biological behavior.SP and KLF Transcription Factors in Digestive Physiology and Diseases.Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury.Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma.Granulocyte macrophage colony-stimulating factor is required for aortic dissection/intramural haematoma.Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma
P2860
Q26772317-BC03E3D1-FB44-492A-846E-B1657E07CA25Q26774851-90358DD8-682A-41BE-8E1A-952698273700Q28272678-0D2C0042-82F8-46AD-9D8E-5E1C7E7296F7Q28384227-AE170793-E8C5-4042-AEFE-5F45BF7B39A5Q28597820-5082B133-54FD-4D68-8E34-873F010FD18AQ33820616-95E9D413-496B-4100-95AE-9C1E890484FEQ34166049-EBD9B5AD-0F68-487A-8B17-41CACD504A9EQ34266462-72BE09AF-7C03-47BD-8186-42DA1D4D0F0EQ34950738-825F0C3B-71E8-45B3-9541-2C3743251C8BQ35024614-2F6D642C-AA1F-4561-A81F-01D1AE5B624DQ35781512-7BE2F109-718C-4A01-9F52-23D05A3F0598Q35857579-D9BF9FA1-A173-49A9-AC0D-6DAF72A21A16Q35966000-D0CB6297-87FF-483F-A1E1-7C48DB1054C9Q36095090-450D9936-EC05-4FCD-9BC2-66641EDF7BF8Q36141301-584A5FE8-7E2A-44D1-971A-97C45FB977C9Q36781204-DAB3C530-579B-4D4F-A750-E7821D1142D1Q38344470-CAF0A2BF-8CAF-4289-B5F9-15BB798CD302Q38752619-6A7EA381-5C82-472E-A4F5-F808B56A3ACDQ39056675-C904C7B5-6126-4E6D-B4EC-76D7FB5172DDQ39111656-D9376015-5D91-44E7-9FD2-A88E25D8E7B7Q39209805-95EF6A1D-D39A-46EB-81A2-68C24E6FC1EBQ39214035-DBAAC2D9-61E5-424A-BC0D-B17763CD314AQ40093274-4AF757B4-1696-4777-BD74-356210866853Q46163229-6320A043-6074-48CC-938C-D4F4B424F768Q50983098-98AF6620-BD54-4195-8EB1-F20A7EFADBB9Q58603892-7346D707-9025-4B96-9468-B9CC627DEC84
P2860
Carcinogen-induced hepatic tumors in KLF6+/- mice recapitulate aggressive human hepatocellular carcinoma associated with p53 pathway deregulation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Carcinogen-induced hepatic tum ...... with p53 pathway deregulation.
@ast
Carcinogen-induced hepatic tum ...... with p53 pathway deregulation.
@en
type
label
Carcinogen-induced hepatic tum ...... with p53 pathway deregulation.
@ast
Carcinogen-induced hepatic tum ...... with p53 pathway deregulation.
@en
prefLabel
Carcinogen-induced hepatic tum ...... with p53 pathway deregulation.
@ast
Carcinogen-induced hepatic tum ...... with p53 pathway deregulation.
@en
P2093
P2860
P50
P356
P1433
P1476
Carcinogen-induced hepatic tum ...... with p53 pathway deregulation
@en
P2093
Diana Vetter
Rebekka Hannivoort
Scott L Friedman
Ursula E Lee
Yujin Hoshida
P2860
P304
P356
10.1002/HEP.24413
P407
P577
2011-06-26T00:00:00Z